NCT00975117

Spermotrend in the Treatment of Male Infertility

Assessment of the Efficacy of Dietary Supplement Spermotrend in the Treatment of Male Infertility

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 86 (estimated)
• Sponsor: Catalysis SL · Industry
• Sex: Male
• Age: 19 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether the administration of the dietary supplement Spermotrend improves spermatogenesis parameters in subjects with male infertility unrelated to major testicular conditions. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks. The estimated number of males with infertility to be recruited and randomized for the study is 86.

Conditions

• Male Infertility

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Placebo	One Placebo tablet (Orally administered) twice a day, for 12 weeks.
DIETARY_SUPPLEMENT	Spermotrend	One Spermotrend tablet (Orally administered) twice a day, for 12 weeks

Timeline

• Start date: 2009-09-01
• Primary completion: 2011-03-01
• Completion: 2011-03-01
• First posted: 2009-09-11
• Last updated: 2011-03-08

Locations

1 site across 1 country: Cuba